Clinical Trial

A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 17, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamic and immunogenicity of single subcutaneous injection of SHR-4658 in healthy volunteers and volunteers with elevated blood pressure.
Trial Details
NCT Number NCT07230145
Lead Sponsor Beijing Suncadia Pharmaceuticals Co., Ltd
Conditions Heart Failure
Enrollment 48 participants
Start Date 2025-11
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-11-17